BVMF/DVAI34 (BVMF/DVAI34)

Brazil Stock Exchange: BVMF/DVAI34 · BRL

R$977

+10.55 (+1.1%)· Recorded snapshot

Market cap	63B
Revenue (ttm)	72.6B
Net income (ttm)	4.4B
EPS (ttm)	R$64.7
P/E (trailing)	15.1x
P/E (forward)	11.8x
Volume	2
Beta	0.80

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 72.6B
Net income (ttm): 4.4B
EPS (ttm): R$64.7
P/E (trailing): 15.1x
P/E (forward): 11.8x
Market cap: 63B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E11.8

P25 n/aP50 n/aP75 n/a

Trailing P/E15.1

P25 n/aP50 n/aP75 n/a

ROE88.5

P25 n/aP50 n/aP75 n/a

ROIC12.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/DVAI34 indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-29
Employees	78,000
Employees change	6,000
Employees growth	8.57%
Enterprise value	BRL 141.3B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1994
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	BRDVAIBDR002
Last earnings date	2026-10-29
Last refreshed	2026-10-29
Market cap	BRL 63B
Next earnings date	2026-10-29
Price	BRL 976.79
Price currency	BRL
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-28
Symbol	bvmf/DVAI34
Website	https://www.davita.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	18.53x
Average P/E ratio (3Y)	13.93x
Average P/E ratio (5Y)	13.48x
Earnings yield	6.63%
EV/Earnings	32.17x
EV/EBIT	12.21x
EV/EBITDA	7.36x
EV/FCF	16.94x
EV/Sales	1.88x
FCF / EV yield	5.9%
FCF yield	13.23%
Forward P/E	11.8x
Graham number	364.29432
Graham upside	-62.7%
Lynch fair value	BRL 340.25
Lynch upside	-65.17%
P/(FCF - SBC) ratio	8.23x
P/(OCF - SBC) ratio	5.9x
P/B ratio	11.27x
P/E ratio	15.09x
P/FCF ratio	7.56x
P/OCF ratio	5.55x
P/S ratio	0.87x
Price/EBITDA ratio	4.3x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.11%
EBITDA margin	20.17%
Effective tax rate	20.66%
FCF margin	11.13%
Gross margin	32.36%
Operating margin	15.11%
Pretax margin	10.48%
Profit margin	6.05%
Profit per employee	BRL 56,290
Profitable quarters	30
Profitable years	26
Revenue per employee	BRL 930,528
ROA	7.51%
ROA (5Y)	6.34%
ROCE	14.25%
ROE	88.48%
ROE (5Y)	46.91%
ROIC	12.26%
ROIC (5Y)	10.25%
SBC / revenue	0.94%
Tax / revenue	2.16%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	18.73%
EPS growth (Q)	55.81%
EPS growth (QoQ)	40.07%
EPS growth 10Y	21.55%
EPS growth 3Y	33.8%
EPS growth 5Y	10.25%
EPS growth quarters	3
EPS growth years	0
FCF growth	24.96%
FCF growth (Q)	57.65%
FCF growth (QoQ)	46.36%
FCF growth 3Y	5.87%
FCF growth 5Y	7.44%
Gross profit growth	5.87%
Gross profit growth (Q)	3.94%
Gross profit growth 3Y	9.53%
Gross profit growth 5Y	4.53%
Net income growth	1.34%
Net income growth (Q)	33.14%
Net income growth (QoQ)	34.36%
Net income growth 3Y	21.91%
Net income growth 5Y	-0.38%
Net income growth quarters	2
Net income growth years	0
OCF growth	17.77%
OCF growth (Q)	51.15%
OCF growth (QoQ)	52.75%
OCF growth 10Y	0.62%
OCF growth 3Y	3.7%
OCF growth 5Y	4.01%
Operating income growth	7.12%
Operating income growth (Q)	7.6%
Operating income growth 3Y	18.18%
Operating income growth 5Y	4.08%
Revenue growth	6.45%
Revenue growth (Q)	5.17%
Revenue growth (QoQ)	4.06%
Revenue growth 10Y	-0.24%
Revenue growth 3Y	6.07%
Revenue growth 5Y	3.91%
Revenue growth quarters	14
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -3B
Depreciation and amortization	BRL 3.8B
EBIT	BRL 11B
EBITDA	BRL 14.6B
EPS	BRL 64.73
Financing cash flow	BRL -7.7B
Free cash flow	BRL 8.3B
Free cash flow minus SBC	BRL 7.7B
Gross profit	BRL 23.5B
Income taxes	BRL 1.6B
Investing cash flow	BRL -3.9B
Net borrowing	BRL 2.7B
Net cash flow	BRL -233.7M
Net income	BRL 4.4B
Operating cash flow minus SBC	BRL 10.7B
Operating income	BRL 11B
Revenue	BRL 72.6B
Stock-based compensation	BRL 681.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.64
Book value per share	BRL -61.98
Debt / EBITDA	3.79
Debt / equity	12.42
Debt / FCF	8.33
Goodwill	BRL 40.6B
Interest coverage	3.65
Long-term assets	BRL 69.4B
Long-term liabilities	BRL 70.9B
Net cash (debt)	BRL -65.9B
Net cash / market cap	-104.54%
Net debt / EBITDA	4.5
Net debt / equity	11.78
Net debt / FCF	7.9
Piotroski F-Score	6
Property, plant and equipment	BRL 27.7B
Shareholders' equity	BRL 5.6B
Tangible book value	BRL -44.5B
Tangible book value per share	BRL -695.43
Total assets	BRL 91.7B
Total cash	BRL 3.6B
Total debt	BRL 69.5B
Total liabilities	BRL 86.2B
WACC	5.9%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.8
Current assets	BRL 22.4B
Current liabilities	BRL 15.3B
Current ratio	1.47
Inventory turnover	63.63
Net working capital	BRL 6.2B
Quick ratio	1.33
Working capital	BRL 6.9B
Working capital turnover	58.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	14.73%
Shareholder yield	14.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 909.74
1D price change	1.09%
1M price change	5.65%
1M total return	5.65%
1W price change	11.13%
1W total return	11.13%
1Y price change	41.94%
1Y return CAGR	41.98%
1Y total return	41.94%
20-day SMA	BRL 923.32
200-day SMA	BRL 864.62
3M price change	-19.39%
3M total return	-19.39%
3Y price change	155.57%
3Y return CAGR	36.71%
3Y total return	155.57%
50-day SMA	BRL 965.47
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 1,253.26
52-week high date	2026-08-03
52-week low	BRL 546.63
52-week low date	2026-01-14
5Y price change	58.5%
5Y return CAGR	9.65%
5Y total return	58.5%
6M price change	30.22%
6M total return	30.22%
All-time high	BRL 1,253.26
All-time high date	2026-08-03
All-time low	BRL 171.72
All-time low date	2019-05-31
Average true range (ATR)	BRL 34.22
Average volume	13
Beta (5Y)	0.8
Change from 52-week high	-22.06%
Change from 52-week low	78.69%
Change from all-time high	-22.06%
Change from all-time low	468.84%
Change from open	-0.69%
Day's gap	1.79%
Dollar volume	BRL 1,954
High price	BRL 983.58
Low price	BRL 976.79
Monthly RSI	57.25
Open price	BRL 983.58
Position in 52-week range	0%
Previous close	BRL 966.24
Price vs 150-day SMA	7.37%
Price vs 20-day SMA	5.79%
Price vs 200-day SMA	12.97%
Price vs 50-day SMA	1.17%
Relative volume	0.15
RSI	55.42
Sharpe ratio	0.17
Sortino ratio	0.36
Volume	2
Weekly RSI	53.75
YTD price change	50.15%
YTD total return	50.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33.9M
Shares change (QoQ)	-4.04%
Shares change (YoY)	-14.73%
Shares held by insiders	1.75%
Shares held by institutions	47.92%
Short ratio	6.3 days

Deeper analysis on BVMF/DVAI34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/DVAI34 report

Is a complete BVMF/DVAI34 research report available?

No complete published report is available for bvmf/DVAI34 (BVMF/DVAI34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/DVAI34 (BVMF/DVAI34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/DVAI34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/DVAI34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/DVAI34

Frequently asked questions